GlobeNewswire Inc.··NaNurix Therapeutics Showcases Protein Degradation Pipeline Potential at AACR 2026
Nurix Therapeutics unveils preclinical data showing protein degradation pipeline effectiveness, with NRX-0305 achieving 142% lifespan extension in melanoma models.
PFESNYGILDNRIXdrug developmentoncology pipeline